What is the market cap difference between JNJ and PFE?

JNJ has a market cap of $574.7B and PFE has a market cap of $153.1B. JNJ has a 3.8x larger market capitalization than PFE

JNJ vs PFE Stock Comparison

Compare Johnson & Johnson (JNJ) and Pfizer, Inc. (PFE) side by side. View price, valuation, dividends, and financial metrics.

Johnson & Johnson

$238.46-1.18%

Healthcare / Drug Manufacturers - General · $574.7B market cap

Pfizer, Inc.

$26.92-1.10%

Healthcare / Drug Manufacturers - General · $153.1B market cap

Both JNJ and PFE operate in the Healthcare sector within the Drug Manufacturers - General industry, making them direct competitors.

JNJ has a 3.8x larger market capitalization than PFE.

PFE trades at a lower P/E ratio (20.1x) compared to JNJ (21.8x), suggesting PFE may be more attractively valued relative to its earnings.

PFE offers a higher dividend yield (6.39%) vs JNJ (2.18%), making it more attractive for income investors.

Looking at profitability, JNJ has a profit margin of 28.5% while PFE's is 12.4%. JNJ converts more of its revenue into profit.

In terms of growth, JNJ has revenue growth of 9.1% versus -1.2% for PFE. JNJ is growing its top line faster.

Which is a better investment, JNJ or PFE?: Both stocks have different strengths. Johnson & Johnson (JNJ) trades at $238.46 with a $574.7B market cap, while Pfizer, Inc. (PFE) trades at $26.92 with a $153.1B market cap. PFE trades at a lower P/E ratio (20.1x) compared to JNJ (21.8x), suggesting PFE may be more attractively valued relative to its earnings. The better choice depends on your investment goals, time horizon, and risk tolerance.
Are JNJ and PFE in the same sector?: Both JNJ and PFE operate in the Healthcare sector within the Drug Manufacturers - General industry, making them direct competitors.
Do JNJ and PFE pay dividends?: PFE offers a higher dividend yield (6.39%) vs JNJ (2.18%), making it more attractive for income investors.